Gupta Akshat, Huang Lilin, Liu Jinpeng, Chen Ke, Xu Ren, Wu Wei
Ray and Stephanie Lane Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
PLoS Genet. 2025 Jul 22;21(7):e1011505. doi: 10.1371/journal.pgen.1011505. eCollection 2025 Jul.
Prolyl hydroxylation, catalyzed by collagen prolyl 4-hydroxylase (P4H), is a crucial post-translational modification involved in collagen biosynthesis. P4HA1, an isoform of P4H, plays a prominent role in stabilizing hypoxia-inducible factor-1α (HIF-1α). P4HA1 is frequently upregulated in highly aggressive triple-negative breast cancer, and has been implicated in tumor progression, metastasis, and chemoresistance. In this study, we investigated the role of P4HA1 in mouse mammary glands by analyzing gene regulatory networks (GRNs) in basal epithelial cells across two mouse groups: control (5Ht) and P4HA1-knockout (6Ho) mice. Specifically, we employed a single-cell network inference approach, integrating single-cell RNA sequencing with the SCENIC pipeline, and incorporated multiple validation strategies to construct gene regulatory networks (GRNs) specific to basal epithelial cells from each mouse group. Despite the inherent challenges of single-cell data, our approach identified reliable and reproducible GRN patterns across both the mouse groups. Based on these patterns, we identified subclusters of basal epithelial cells with similar regulatory profiles across the two mouse groups, as well as a unique subcluster in the control mice with a distinct regulatory pattern absent in the P4HA1-deficient 6Ho mice. This unique subcluster exhibited concurrent activation of stem cell development and inflammatory response pathways, suggesting the role of P4HA1 in regulating these biological processes linked to cancer initiation and progression. We verified these findings through multiple approaches, including in silico validation using multiple external datasets as well as experimental validation. Given that the loss of P4HA1 may disrupt stem cell development and inflammation response, our results suggest that targeting P4HA1 may offer a promising therapeutic strategy for breast cancer treatment.
由胶原蛋白脯氨酰4-羟化酶(P4H)催化的脯氨酰羟化是胶原蛋白生物合成中一种关键的翻译后修饰。P4HA1是P4H的一种同工型,在稳定缺氧诱导因子-1α(HIF-1α)方面发挥着重要作用。P4HA1在侵袭性很强的三阴性乳腺癌中经常上调,并与肿瘤进展、转移和化疗耐药有关。在本研究中,我们通过分析两个小鼠组(对照组(5Ht)和P4HA1基因敲除组(6Ho)小鼠)基底上皮细胞中的基因调控网络(GRN),研究了P4HA1在小鼠乳腺中的作用。具体而言,我们采用了一种单细胞网络推理方法,将单细胞RNA测序与SCENIC管道相结合,并纳入多种验证策略,以构建每个小鼠组基底上皮细胞特有的基因调控网络(GRN)。尽管单细胞数据存在固有挑战,但我们的方法在两个小鼠组中都识别出了可靠且可重复的GRN模式。基于这些模式,我们在两个小鼠组中识别出了具有相似调控特征的基底上皮细胞亚群,以及对照组小鼠中一个独特的亚群,其具有P4HA1缺陷的6Ho小鼠中不存在的独特调控模式。这个独特的亚群表现出干细胞发育和炎症反应途径的同时激活,表明P4HA1在调节与癌症发生和进展相关的这些生物学过程中的作用。我们通过多种方法验证了这些发现,包括使用多个外部数据集进行的计算机模拟验证以及实验验证。鉴于P4HA1的缺失可能会破坏干细胞发育和炎症反应,我们的结果表明靶向P4HA1可能为乳腺癌治疗提供一种有前景的治疗策略。